Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective

Y Yang, S Li, Y Wang, Y Zhao, Q Li - Signal transduction and targeted …, 2022 - nature.com
Protein tyrosine kinases (PTKs) are a class of proteins with tyrosine kinase activity that
phosphorylate tyrosine residues of critical molecules in signaling pathways. Their basal …

Molecular targeting therapies for neuroblastoma: Progress and challenges

A Zafar, W Wang, G Liu, X Wang, W Xian… - Medicinal research …, 2021 - Wiley Online Library
There is an urgent need to identify novel therapies for childhood cancers. Neuroblastoma is
the most common pediatric solid tumor, and accounts for~ 15% of childhood cancer‐related …

The genetic landscape of high-risk neuroblastoma

TJ Pugh, O Morozova, EF Attiyeh, S Asgharzadeh… - Nature …, 2013 - nature.com
Neuroblastoma is a malignancy of the developing sympathetic nervous system that often
presents with widespread metastatic disease, resulting in survival rates of less than 50%. To …

Neuroblastoma and MYCN

M Huang, WA Weiss - Cold Spring …, 2013 - perspectivesinmedicine.cshlp.org
Neuroblastoma, the most common extracranial solid tumor of childhood, is thought to
originate from undifferentiated neural crest cells. Amplification of the MYC family member …

Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology

B Hallberg, RH Palmer - Nature Reviews Cancer, 2013 - nature.com
The burgeoning field of anaplastic lymphoma kinase (ALK) in cancer encompasses many
cancer types, from very rare cancers to the more prevalent non-small-cell lung cancer …

Pan-neuroblastoma analysis reveals age-and signature-associated driver alterations

SW Brady, Y Liu, X Ma, AM Gout, K Hagiwara… - Nature …, 2020 - nature.com
Neuroblastoma is a pediatric malignancy with heterogeneous clinical outcomes. To better
understand neuroblastoma pathogenesis, here we analyze whole-genome, whole-exome …

ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma

SC Bresler, DA Weiser, PJ Huwe, JH Park, K Krytska… - Cancer cell, 2014 - cell.com
Genetic studies have established anaplastic lymphoma kinase (ALK), a cell surface receptor
tyrosine kinase, as a tractable molecular target in neuroblastoma. We describe …

Neuroblastoma: paradigm for precision medicine

MS Irwin, JR Park - Pediatric Clinics, 2015 - pediatric.theclinics.com
Neuroblastoma (NB), the most common extracranial tumor of childhood, is a cancer of
primordial neural crest cells that give rise to sympathetic neural ganglia and adrenal …

ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK. CAR-T cells

E Bergaggio, WT Tai, A Aroldi, C Mecca, E Landoni… - Cancer cell, 2023 - cell.com
Selection of the best tumor antigen is critical for the therapeutic success of chimeric antigen
receptor (CAR) T cells in hematologic malignancies and solid tumors. The anaplastic …

Proteolysis targeting chimeras (PROTACs) of anaplastic lymphoma kinase (ALK)

C Zhang, XR Han, X Yang, B Jiang, J Liu… - European journal of …, 2018 - Elsevier
Anaplastic lymphoma kinase (ALK) activation has been associated with many types of
human cancer. Significant efforts have been devoted to the development of ALK inhibitors to …